Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2024-02-24 Regulatory Filings
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
Resignation
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (281 characters) and does not provide any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. Therefore, it falls under the fallback category for miscellaneous filings that do not fit other categories, which is Regulatory Filings (RNS).
2024-02-24 English
Resignation of CFO
Regulatory Filings
2024-02-24 English
Financial Result Updates
Regulatory Filings
2024-02-14 English
Results Q3FY24
Regulatory Filings
2024-02-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (68 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report title, no regulatory references, no announcements, or any other information to classify it as a specific filing type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal or empty content defaults to Regulatory Filings (RNS) as a fallback category.
2024-01-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 68 characters) and contains no substantive content, financial data, or any report-related information. It only mentions an omitted picture and has no indication of being a report or announcement. Given the lack of content, the document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings.
2024-01-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.